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Can Contrast-Enhanced Cardiac Magnetic Resonance
Assess Inﬂammation of the Coronary Wall?*
Debiao Li, PHD,† Zahi A. Fayad, PHD,‡ David A. Bluemke, MD, PHD§
Chicago, Illinois; New York, New York; and Bethesda, MarylandAtherosclerotic heart disease remains the most com-
mon cause of death and disability for both men and
women in the industrialized world. By traditional
methods, atherosclerosis can only be diagnosed in ad-
vanced stages when the vessel lumen is narrowed and/or
blood flow to an organ is reduced. Early assessment of
atherosclerosis by direct and noninvasive visualization
and tissue characterization of the vessel wall is one of
the significant advances in cardiac magnetic resonance
(CMR) in recent years. Various soft-tissue contrasts
available with CMR permit clear delineation of the
different components of the atherosclerotic plaque,
including lipid core, fibrous cap, calcification, and
thrombus formation, as demonstrated in the carotid
artery (1), aorta (2,3), and peripheral vessels (4,5). It
seems likely that similar mechanisms are present in the
coronary arterial wall as well.
See page 580
Inflammation plays a major role in various stages of
atherosclerosis. Endothelial dysfunction and damage
to the endothelium is believed to initiate the process of
atherosclerosis by stimulating the migration and pro-
liferation of smooth-muscle cells through the inflam-
matory response. Continued inflammation and accu-
mulation of macrophages, T cells, and smooth-muscle
cells and formation of fibrous tissue lead to advanced
lesions covered by a protective fibrous cap that overlies
a core of lipid and necrotic tissue (6). The destructive
enzymes and cytokines produced by the inflammation
*Editorials published in JACC: Cardiovascular Imaging reflect the views of
the authors and do not necessarily represent the views of JACC: Cardio-
vascular Imaging or the American College of Cardiology.
From the †Departments of Radiology and Biomedical Engineering,
Northwestern University, Chicago, Illinois; ‡Translational and Molecular
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York; and §Radiology and Imaging Sciences, National Institutes of
Health, Clinical Center, Bethesda, Maryland.at the core of the plaque could lead to the breakdown
of the fibrous cap of the plaque, which allows flowing
blood to be exposed to the thrombogenic lipid core
and can precipitate acute blockage of the artery by clot,
causing acute events such as myocardial infarction,
stroke, or peripheral thrombus embolization (7).
Delayed-enhancement with contrast-enhanced
CMR with nonspecific extracellular agents has been
demonstrated in several inflammatory vessel wall dis-
eases, such as giant cell arteritis (8) and Takayasu’s
arteritis (9), myocarditis (10), and atherosclerotic
plaques. The CMR markers of plaque in the aorta
and carotid arteries, including increased contrast-
enhancement, were linked to elevated serum mark-
ers of inflammation in humans (11). Contrast-
enhancement related to atherosclerotic plaques has
been demonstrated in the carotid artery (12,13) and
atherosclerotic abdominal aortic aneurysm (3). In
the carotid artery, the signal increase was noted to
occur most prominently in the fibrous cap rich in
plaque neovascularization in histology (12). In the
atherosclerotic abdominal aortic aneurysm, selective
enhancement was also shown in the fibrous cap
with a greater contrast-enhancement in patients
with infiltration of inflammatory cells than those
without inflammation (3). It is likely that inflam-
mation causes increased water content in the arterial
wall and thus increased accumulation of the
gadolinium-based contrast agent. In the study by
Kerwin et al. (14), strong associations between
histologic markers of inflammation (macrophage,
neovasculature, and loose matrix) and quantitative
indices generated from dynamic contrast-enhanced
CMR images in patients scheduled for carotid
endarterectomy were observed. The results of this
study also elucidate the pathways of plaque en-
hancement during gadolinium-enhanced CMR of
the carotid arteries, including increased entry of
contrast agent into the plaque measured by the
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590mount of neovasculature within the plaque, in-
reased delivery of the contrast agent into the
xtravascular extracellular space, and a combination
f increased neovasculature supply and permeabil-
ty. Macrophages were found to be the dominant
ediator of plaque permeability.
Coronary artery plaque imaging presents consider-
ble technical challenges to the CMR system. Coro-
ary artery motion during the respiratory and cardiac
ycles requires accurate motion compensation during
ata acquisition. The small size and tortuous courses
f coronary arteries necessitate high-resolution imag-
ng. Despite these challenges, Fayad et al. (15) dem-
nstrated the significantly increased coronary artery
all thickness in patients with 40% stenosis as
ssessed by X-ray angiography as compared with
ormal subjects with a 2-dimensional black-blood
ethod. Increased coronary wall thickness has been
hown to correlate with increased numbers of risk
actors for coronary artery disease (16).
Botnar et al. (17) developed a 3-dimensional spiral
cquisition technique for coronary vessel wall imaging,
hich uses a local inversion method to suppress the
uminal blood signal in order to clearly delineate the
essel wall. With this method, Kim et al. (18) detected
ositive arterial remodeling in patients with nonsig-
ificant coronary artery disease. Recently, selective
laque visualization and differentiation of coronary
laque types were demonstrated in inversion-recovery
repared, contrast-enhanced CMR as confirmed by
-ray angiography and multidetector computed to-
ography (19,20).
In this issue of iJACC, Ibrahim et al. (21) per-
ormed serial contrast-enhanced CMR of coronary
rteries in patients with acute myocardial infarction
AMI) at 2 different times after coronary intervention
stenting of the infarct-related artery). At baseline (6
ays after intervention), patients demonstrated a sig-
ificantly increased coronary vessel wall signal, com-
ared with a control group that also received an
ntravenous administration of 0.2 mmol/kg gadolinium–
iethylenetriaminepentaacetic acid. Coronary wall
ontrast enhancement also significantly correlated
ith the degree of lumen narrowing by X-ray angiog-
aphy. At follow-up (3 months after intervention), the
oronary vessel signal enhancement decreased signif-
cantly as compared with that measured at baseline,
hich seemed to parallel the decline in systemic
nflammatory activity as measured by C-reactive pro-
ein. The authors conclude that, due to the short time
eriod between the 2 studies, it is not likely that the
ignificantly decreased coronary wall contrast en-
ancement observed at the follow-up study is caused sy plaque volume regression but rather associated with
he regression of systemic inflammation.
The aforementioned findings of contrast enhance-
ent by CMR were not reported with respect to the
ite of the infarct-related artery but rather to a gener-
lized assessment that included all proximal coronary
essel segments with 25% narrowing. Of note, 1
xtracoronary vessel, the descending thoracic aorta,
as also included, and it did not show enhancement.
Certain limitations exist with the study. The out-
ome variable was not strictly “enhancement” of the
essel, because no imaging was performed before
adolinium administration. A surrogate for enhance-
ent was contrast-to-noise ratio (CNR) or simply
ow bright the artery appeared relative to the adjacent
issue. The authors reported higher CNR level in
essels with higher degrees of atherosclerotic narrow-
ng. This is likely due simply to the greater plaque
olume when the vessel is thicker. However, in paired
nalysis, the vessels showed lower CNR 3 months
fter infarction. This suggests resolution of “enhance-
ent” over time. Unfortunately, the CMR technique
s highly dependent on the choice of the inversion
ecovery time, introducing an element of uncertainty
ue to potential blood T1 changes during data acqui-
ition. Further improvement in spatial resolution will
educe partial volume effects, potentially allowing
irect visualization of the enhanced vessel wall. In
ddition, the timing of data acquisition after contrast
dministration needs to be optimized. Various delay
imes (30 min to 3 h) have been used for coronary wall
maging (19–21).
The mechanism of coronary wall enhancement is
ncompletely elucidated for the new observation in
his work. The gadolinium-based contrast agent
hows little specificity for tissue type or mechanism of
nhancement. Various processes have been proposed
or enhancing tissues on CMR, including increased
istribution volume of water or electrostatic interac-
ion of the contrast agent with various tissue compo-
ents. Collagen/fibrosis, edema, inflammation, and
umors all show enhancement. The authors showed
hat C-reactive protein levels were high at the time of
he infarction and diminished 3 months later, along
ith diminishing arterial enhancement. This is inter-
sting but does not suggest a mechanism for selective
nhancement of only coronary arteries and not tho-
acic aorta.
Although the mechanism of coronary enhancement
s incompletely understood, the findings of this study
uggest potential utility as a marker for disease. It
ould be of great interest if the observations of thistudy could be related to coronary inflammation that
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591xists in the absence of an overt arterial infarction.
etection of small plaque components by CMR is
ikely to be improved after addition of a contrast agent
hat improves CNR. Certain plaque components of
nterest including the collagen cap uniquely show
nhancement by CMR. With further development,
he method used in this study might reveal a nonin-
asive marker in identifying plaque components, vol-
me, or inflammation versus edema.
In summary, the authors should be congratulated
or conducting the first study in humans to demon-
trate the feasibility of gadolinium contrast-enhanced
MR for assessing serial changes in the coronary283–7. 28:1108–15.urther improvement and validation, it is feasible that
his or other related methods could prove useful for
oing beyond noninvasive coronary luminography to
otentially allow identification of patients with active
nd potentially unstable coronary plaque who might
enefit from more aggressive medical treatment or
arlier intervention. It might also provide a valuable
eans for monitoring the effectiveness of novel ther-
pies for coronary atherosclerosis.
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